Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 124 | 2024 | 3753 | 20.900 |
Why?
|
Rheumatic Diseases | 46 | 2024 | 654 | 9.100 |
Why?
|
Lung Diseases, Interstitial | 31 | 2024 | 918 | 8.640 |
Why?
|
Antirheumatic Agents | 42 | 2024 | 1369 | 8.080 |
Why?
|
Rheumatology | 23 | 2024 | 616 | 4.360 |
Why?
|
Autoimmune Diseases | 16 | 2024 | 2244 | 2.540 |
Why?
|
Smoking | 24 | 2024 | 9055 | 2.270 |
Why?
|
Bronchiectasis | 3 | 2024 | 139 | 2.220 |
Why?
|
Methotrexate | 14 | 2024 | 1718 | 2.200 |
Why?
|
Hydroxychloroquine | 11 | 2021 | 426 | 1.770 |
Why?
|
Rheumatoid Factor | 8 | 2023 | 184 | 1.760 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 9 | 2024 | 3201 | 1.730 |
Why?
|
Lupus Erythematosus, Systemic | 21 | 2024 | 2157 | 1.680 |
Why?
|
Arthritis, Psoriatic | 5 | 2023 | 219 | 1.540 |
Why?
|
Nurses | 16 | 2023 | 2477 | 1.290 |
Why?
|
Risk Factors | 76 | 2024 | 74241 | 1.250 |
Why?
|
Biological Products | 7 | 2023 | 915 | 1.200 |
Why?
|
Autoantibodies | 14 | 2024 | 2119 | 1.150 |
Why?
|
Women's Health | 4 | 2021 | 2070 | 1.130 |
Why?
|
Sarcoidosis | 3 | 2019 | 537 | 1.120 |
Why?
|
Health Behavior | 5 | 2022 | 2641 | 1.100 |
Why?
|
Humans | 236 | 2024 | 761222 | 1.090 |
Why?
|
Tobacco Smoke Pollution | 3 | 2021 | 821 | 1.070 |
Why?
|
Asthma | 8 | 2023 | 6230 | 1.060 |
Why?
|
Autoimmunity | 4 | 2024 | 1356 | 1.040 |
Why?
|
Middle Aged | 114 | 2024 | 220858 | 1.000 |
Why?
|
Arthritis | 3 | 2024 | 681 | 0.990 |
Why?
|
Risk Reduction Behavior | 4 | 2021 | 1111 | 0.980 |
Why?
|
Air Pollution | 3 | 2024 | 2351 | 0.940 |
Why?
|
Lung Transplantation | 2 | 2024 | 1307 | 0.930 |
Why?
|
Sinusitis | 3 | 2024 | 990 | 0.930 |
Why?
|
Incidence | 32 | 2024 | 21366 | 0.920 |
Why?
|
Disease Progression | 13 | 2024 | 13511 | 0.910 |
Why?
|
Glucocorticoids | 12 | 2024 | 2159 | 0.910 |
Why?
|
Female | 134 | 2024 | 392552 | 0.890 |
Why?
|
Spirometry | 2 | 2024 | 928 | 0.880 |
Why?
|
Bone Diseases | 2 | 2019 | 418 | 0.850 |
Why?
|
Case-Control Studies | 26 | 2024 | 22174 | 0.830 |
Why?
|
Prospective Studies | 45 | 2024 | 54437 | 0.800 |
Why?
|
Gout | 4 | 2022 | 621 | 0.790 |
Why?
|
Adult | 84 | 2024 | 221120 | 0.720 |
Why?
|
Male | 94 | 2024 | 360703 | 0.710 |
Why?
|
Antigens, Viral | 1 | 2024 | 989 | 0.700 |
Why?
|
Patient Education as Topic | 4 | 2019 | 2317 | 0.700 |
Why?
|
Smoking Cessation | 4 | 2019 | 2056 | 0.670 |
Why?
|
Air Pollutants | 3 | 2024 | 2889 | 0.660 |
Why?
|
Psoriasis | 3 | 2023 | 946 | 0.660 |
Why?
|
Antimalarials | 3 | 2020 | 907 | 0.650 |
Why?
|
Pulmonary Emphysema | 1 | 2024 | 683 | 0.640 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2019 | 45 | 0.640 |
Why?
|
Early Diagnosis | 1 | 2024 | 1186 | 0.630 |
Why?
|
Mucin-5B | 4 | 2023 | 148 | 0.620 |
Why?
|
Aged | 56 | 2024 | 169292 | 0.600 |
Why?
|
Climate Change | 1 | 2024 | 498 | 0.590 |
Why?
|
Risk Assessment | 22 | 2024 | 24022 | 0.590 |
Why?
|
Life Style | 6 | 2022 | 3907 | 0.570 |
Why?
|
Environmental Exposure | 5 | 2024 | 4479 | 0.550 |
Why?
|
Gastrointestinal Agents | 1 | 2021 | 509 | 0.550 |
Why?
|
Pneumonia | 2 | 2020 | 2142 | 0.540 |
Why?
|
Antiviral Agents | 4 | 2024 | 3048 | 0.540 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2018 | 190 | 0.540 |
Why?
|
Public Opinion | 1 | 2020 | 485 | 0.540 |
Why?
|
Peptides, Cyclic | 4 | 2022 | 392 | 0.530 |
Why?
|
Respiratory Mucosa | 1 | 2020 | 436 | 0.530 |
Why?
|
Sulfasalazine | 1 | 2016 | 84 | 0.530 |
Why?
|
Coronavirus Infections | 8 | 2021 | 3093 | 0.520 |
Why?
|
Lung | 11 | 2024 | 9979 | 0.510 |
Why?
|
Immunosuppressive Agents | 4 | 2022 | 4190 | 0.510 |
Why?
|
Seafood | 1 | 2019 | 393 | 0.500 |
Why?
|
Drug Monitoring | 1 | 2021 | 961 | 0.500 |
Why?
|
Fusarium | 1 | 2015 | 51 | 0.500 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2018 | 4014 | 0.500 |
Why?
|
Gastritis | 1 | 2017 | 199 | 0.490 |
Why?
|
Health Education | 2 | 2018 | 1049 | 0.490 |
Why?
|
Bariatric Surgery | 3 | 2020 | 991 | 0.490 |
Why?
|
Granuloma | 1 | 2017 | 326 | 0.480 |
Why?
|
Diet | 6 | 2019 | 8048 | 0.480 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 353 | 0.470 |
Why?
|
Registries | 11 | 2023 | 8246 | 0.470 |
Why?
|
Pneumonia, Viral | 7 | 2020 | 3215 | 0.470 |
Why?
|
Family | 2 | 2016 | 3192 | 0.460 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1780 | 0.420 |
Why?
|
Vital Capacity | 3 | 2024 | 970 | 0.420 |
Why?
|
Antibodies, Antinuclear | 5 | 2024 | 342 | 0.420 |
Why?
|
Vaccination | 12 | 2024 | 3369 | 0.390 |
Why?
|
Time Factors | 18 | 2024 | 39957 | 0.390 |
Why?
|
Cardiovascular Diseases | 8 | 2021 | 15521 | 0.390 |
Why?
|
Arthritis, Infectious | 1 | 2015 | 347 | 0.390 |
Why?
|
Proportional Hazards Models | 13 | 2021 | 12474 | 0.390 |
Why?
|
Myositis | 3 | 2024 | 270 | 0.390 |
Why?
|
Periodicals as Topic | 1 | 2022 | 1463 | 0.370 |
Why?
|
Respiratory Function Tests | 5 | 2024 | 1685 | 0.370 |
Why?
|
Retrospective Studies | 17 | 2024 | 80675 | 0.360 |
Why?
|
Genetic Predisposition to Disease | 11 | 2024 | 17897 | 0.350 |
Why?
|
United States | 30 | 2024 | 72341 | 0.350 |
Why?
|
Severity of Illness Index | 7 | 2022 | 15841 | 0.330 |
Why?
|
Exercise | 4 | 2022 | 5874 | 0.330 |
Why?
|
Logistic Models | 9 | 2022 | 13249 | 0.330 |
Why?
|
Lung Diseases | 1 | 2019 | 1910 | 0.320 |
Why?
|
Cohort Studies | 22 | 2024 | 41496 | 0.320 |
Why?
|
Connective Tissue Diseases | 3 | 2024 | 285 | 0.320 |
Why?
|
Sex Factors | 7 | 2021 | 10553 | 0.310 |
Why?
|
Obesity | 6 | 2020 | 12940 | 0.310 |
Why?
|
Environment | 1 | 2014 | 1122 | 0.300 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2018 | 1390 | 0.300 |
Why?
|
Serologic Tests | 2 | 2021 | 381 | 0.300 |
Why?
|
Physicians | 2 | 2023 | 4584 | 0.300 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2019 | 64 | 0.290 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9187 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2254 | 0.290 |
Why?
|
Prednisone | 5 | 2023 | 1565 | 0.290 |
Why?
|
Body Weight | 1 | 2017 | 4618 | 0.280 |
Why?
|
Musculoskeletal Diseases | 2 | 2023 | 598 | 0.270 |
Why?
|
Body Mass Index | 9 | 2021 | 12952 | 0.270 |
Why?
|
Prevalence | 6 | 2023 | 15721 | 0.260 |
Why?
|
Immunologic Factors | 3 | 2024 | 1589 | 0.260 |
Why?
|
Inflammation | 6 | 2024 | 10759 | 0.250 |
Why?
|
Pandemics | 10 | 2023 | 8663 | 0.250 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13386 | 0.240 |
Why?
|
Neoplasms | 4 | 2024 | 22142 | 0.240 |
Why?
|
Risk | 4 | 2021 | 9616 | 0.240 |
Why?
|
Double-Blind Method | 6 | 2021 | 12341 | 0.230 |
Why?
|
Scleroderma, Systemic | 3 | 2024 | 345 | 0.230 |
Why?
|
Research Design | 4 | 2022 | 6180 | 0.230 |
Why?
|
Remission Induction | 3 | 2021 | 2392 | 0.220 |
Why?
|
Bone and Bones | 1 | 2014 | 2568 | 0.220 |
Why?
|
Antibodies, Viral | 6 | 2024 | 3149 | 0.220 |
Why?
|
Age Factors | 7 | 2020 | 18384 | 0.220 |
Why?
|
I-kappa B Kinase | 1 | 2024 | 249 | 0.210 |
Why?
|
Adenosine Monophosphate | 1 | 2024 | 231 | 0.210 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1838 | 0.210 |
Why?
|
Ikaros Transcription Factor | 1 | 2024 | 232 | 0.210 |
Why?
|
Odds Ratio | 6 | 2022 | 9652 | 0.210 |
Why?
|
Folic Acid | 2 | 2021 | 1323 | 0.200 |
Why?
|
Paraneoplastic Syndromes | 1 | 2024 | 155 | 0.200 |
Why?
|
Influenza, Human | 1 | 2013 | 1521 | 0.200 |
Why?
|
Forced Expiratory Volume | 2 | 2024 | 1813 | 0.200 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2023 | 125 | 0.190 |
Why?
|
Receptors, Interleukin-6 | 1 | 2023 | 224 | 0.190 |
Why?
|
Alanine | 1 | 2024 | 608 | 0.190 |
Why?
|
Oral Health | 2 | 2019 | 491 | 0.190 |
Why?
|
Hospitalization | 8 | 2022 | 10707 | 0.190 |
Why?
|
Comorbidity | 8 | 2024 | 10516 | 0.180 |
Why?
|
Depression | 1 | 2021 | 8132 | 0.180 |
Why?
|
Lymphoma, T-Cell | 1 | 2023 | 303 | 0.180 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5773 | 0.180 |
Why?
|
Myasthenia Gravis | 1 | 2023 | 214 | 0.180 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2270 | 0.180 |
Why?
|
Interleukin-12 | 1 | 2023 | 578 | 0.170 |
Why?
|
Alcohol Drinking | 3 | 2020 | 4027 | 0.170 |
Why?
|
Emphysema | 1 | 2022 | 238 | 0.170 |
Why?
|
Treatment Outcome | 9 | 2023 | 64681 | 0.170 |
Why?
|
Premature Birth | 2 | 2023 | 1784 | 0.170 |
Why?
|
Thorax | 1 | 2022 | 555 | 0.170 |
Why?
|
Drug Resistance, Viral | 1 | 2024 | 862 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 612 | 0.160 |
Why?
|
Immunity, Humoral | 1 | 2023 | 598 | 0.160 |
Why?
|
Postmenopause | 2 | 2018 | 2514 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 165 | 0.160 |
Why?
|
Macrophage Activation | 1 | 2022 | 552 | 0.160 |
Why?
|
Health Surveys | 3 | 2019 | 4037 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 15920 | 0.160 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4242 | 0.150 |
Why?
|
Immunocompromised Host | 2 | 2020 | 858 | 0.150 |
Why?
|
Nutritive Value | 1 | 2021 | 347 | 0.150 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.150 |
Why?
|
Area Under Curve | 3 | 2021 | 1636 | 0.150 |
Why?
|
Diet Surveys | 2 | 2021 | 1161 | 0.150 |
Why?
|
Granzymes | 1 | 2019 | 276 | 0.150 |
Why?
|
Aged, 80 and over | 10 | 2022 | 58952 | 0.150 |
Why?
|
Steroids | 1 | 2023 | 929 | 0.150 |
Why?
|
Lung Injury | 1 | 2022 | 422 | 0.150 |
Why?
|
Multivariate Analysis | 6 | 2020 | 12052 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12976 | 0.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 514 | 0.140 |
Why?
|
Respiration, Artificial | 4 | 2022 | 2631 | 0.140 |
Why?
|
Occupational Therapy | 1 | 2019 | 139 | 0.140 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39127 | 0.140 |
Why?
|
Mass Media | 1 | 2020 | 303 | 0.140 |
Why?
|
Demography | 1 | 2022 | 1641 | 0.140 |
Why?
|
Obesity, Abdominal | 1 | 2020 | 373 | 0.140 |
Why?
|
Medical History Taking | 1 | 2021 | 773 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2023 | 6304 | 0.140 |
Why?
|
Genome-Wide Association Study | 4 | 2024 | 12676 | 0.140 |
Why?
|
Sweden | 1 | 2020 | 1379 | 0.140 |
Why?
|
Viral Vaccines | 1 | 2022 | 593 | 0.140 |
Why?
|
Interinstitutional Relations | 1 | 2018 | 236 | 0.140 |
Why?
|
Citrulline | 1 | 2016 | 107 | 0.130 |
Why?
|
Metabolome | 2 | 2020 | 989 | 0.130 |
Why?
|
Military Medicine | 1 | 2018 | 184 | 0.130 |
Why?
|
Life Change Events | 1 | 2021 | 952 | 0.130 |
Why?
|
Cyclooxygenase 2 | 1 | 2018 | 597 | 0.130 |
Why?
|
Chemokines | 1 | 2020 | 956 | 0.130 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2452 | 0.130 |
Why?
|
Sleep Deprivation | 1 | 2022 | 847 | 0.130 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 780 | 0.130 |
Why?
|
Epidemiologic Studies | 1 | 2019 | 677 | 0.130 |
Why?
|
Myocarditis | 1 | 2023 | 792 | 0.130 |
Why?
|
Phosphoproteins | 1 | 2024 | 2444 | 0.130 |
Why?
|
Rheumatic Fever | 1 | 2015 | 73 | 0.120 |
Why?
|
Osteonecrosis | 1 | 2017 | 228 | 0.120 |
Why?
|
Communication | 2 | 2020 | 3872 | 0.120 |
Why?
|
Needs Assessment | 2 | 2019 | 1141 | 0.120 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 534 | 0.120 |
Why?
|
Prognosis | 3 | 2021 | 29688 | 0.120 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2018 | 303 | 0.120 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 531 | 0.120 |
Why?
|
HLA Antigens | 1 | 2020 | 1331 | 0.120 |
Why?
|
Arginine | 1 | 2018 | 920 | 0.120 |
Why?
|
Publishing | 1 | 2022 | 832 | 0.120 |
Why?
|
Military Personnel | 2 | 2021 | 1246 | 0.120 |
Why?
|
Electronic Health Records | 2 | 2024 | 4822 | 0.120 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 63 | 0.120 |
Why?
|
Complementary Therapies | 1 | 2019 | 487 | 0.120 |
Why?
|
Fibrinogen | 1 | 2018 | 888 | 0.120 |
Why?
|
Genes, MHC Class II | 1 | 2015 | 433 | 0.120 |
Why?
|
Algorithms | 3 | 2020 | 14025 | 0.120 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 465 | 0.110 |
Why?
|
Nausea | 1 | 2017 | 678 | 0.110 |
Why?
|
Gastric Mucosa | 1 | 2017 | 603 | 0.110 |
Why?
|
Hematinics | 1 | 2017 | 282 | 0.110 |
Why?
|
Vomiting | 1 | 2017 | 650 | 0.110 |
Why?
|
Amino Acids | 2 | 2021 | 1703 | 0.110 |
Why?
|
Biomedical Research | 2 | 2020 | 3434 | 0.110 |
Why?
|
Carotenoids | 1 | 2017 | 621 | 0.110 |
Why?
|
Epitopes | 2 | 2017 | 2504 | 0.110 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14610 | 0.110 |
Why?
|
Fibrosis | 1 | 2021 | 2052 | 0.110 |
Why?
|
Endosonography | 1 | 2017 | 608 | 0.110 |
Why?
|
Aminolevulinic Acid | 1 | 2014 | 145 | 0.110 |
Why?
|
Overweight | 2 | 2014 | 2418 | 0.110 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2182 | 0.110 |
Why?
|
Carbonated Beverages | 1 | 2014 | 210 | 0.110 |
Why?
|
Hormone Replacement Therapy | 1 | 2018 | 751 | 0.110 |
Why?
|
Spondylitis, Ankylosing | 1 | 2014 | 155 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 588 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4574 | 0.100 |
Why?
|
Antibody Formation | 3 | 2023 | 1391 | 0.100 |
Why?
|
Physical Examination | 1 | 2019 | 1255 | 0.100 |
Why?
|
Particulate Matter | 1 | 2024 | 2597 | 0.100 |
Why?
|
Mentors | 1 | 2018 | 663 | 0.100 |
Why?
|
Dietary Sucrose | 1 | 2014 | 243 | 0.100 |
Why?
|
Young Adult | 9 | 2022 | 59222 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20588 | 0.100 |
Why?
|
Upper Extremity | 1 | 2017 | 658 | 0.100 |
Why?
|
Immunity, Innate | 1 | 2024 | 3044 | 0.100 |
Why?
|
Up-Regulation | 1 | 2021 | 4111 | 0.100 |
Why?
|
Age of Onset | 1 | 2019 | 3307 | 0.100 |
Why?
|
Rare Diseases | 1 | 2017 | 624 | 0.100 |
Why?
|
Information Dissemination | 1 | 2020 | 1129 | 0.100 |
Why?
|
Weight Gain | 2 | 2022 | 2349 | 0.090 |
Why?
|
Cytokines | 3 | 2022 | 7386 | 0.090 |
Why?
|
Gastrectomy | 1 | 2015 | 672 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 748 | 0.090 |
Why?
|
Alleles | 4 | 2024 | 6857 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 1 | 2020 | 2247 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3688 | 0.090 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 26072 | 0.090 |
Why?
|
Hypersensitivity | 1 | 2019 | 1167 | 0.090 |
Why?
|
Health Communication | 1 | 2013 | 213 | 0.080 |
Why?
|
China | 3 | 2020 | 2374 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1155 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 1078 | 0.080 |
Why?
|
Menopause | 1 | 2017 | 1646 | 0.080 |
Why?
|
Lower Extremity | 1 | 2017 | 1201 | 0.080 |
Why?
|
Immunophenotyping | 2 | 2024 | 1867 | 0.080 |
Why?
|
Chloroquine | 2 | 2020 | 274 | 0.080 |
Why?
|
Kidney | 2 | 2021 | 7033 | 0.080 |
Why?
|
Azithromycin | 2 | 2020 | 199 | 0.080 |
Why?
|
Coronary Artery Disease | 2 | 2018 | 6506 | 0.080 |
Why?
|
Antidepressive Agents | 1 | 2021 | 2893 | 0.080 |
Why?
|
Phenotype | 3 | 2017 | 16575 | 0.080 |
Why?
|
Motivation | 1 | 2018 | 2002 | 0.080 |
Why?
|
Survival Analysis | 2 | 2017 | 10088 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2018 | 3821 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6486 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2024 | 11855 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2813 | 0.070 |
Why?
|
Patient Care Team | 1 | 2019 | 2515 | 0.070 |
Why?
|
Disease | 1 | 2013 | 670 | 0.070 |
Why?
|
Gastric Bypass | 1 | 2015 | 818 | 0.070 |
Why?
|
Societies, Medical | 3 | 2024 | 3923 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1885 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2421 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8457 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10203 | 0.070 |
Why?
|
Insurance, Health | 1 | 2018 | 2493 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2019 | 3608 | 0.060 |
Why?
|
Genetic Variation | 2 | 2024 | 6567 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2374 | 0.060 |
Why?
|
Intestines | 1 | 2014 | 1908 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5321 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18222 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1812 | 0.060 |
Why?
|
International Classification of Diseases | 2 | 2023 | 915 | 0.060 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2024 | 32 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5694 | 0.060 |
Why?
|
Weight Loss | 1 | 2015 | 2680 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8002 | 0.060 |
Why?
|
Laparoscopy | 1 | 2015 | 2035 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2014 | 7804 | 0.060 |
Why?
|
Child | 4 | 2023 | 80154 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7407 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9327 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2018 | 3407 | 0.050 |
Why?
|
Endemic Diseases | 1 | 2023 | 191 | 0.050 |
Why?
|
Sjogren's Syndrome | 1 | 2024 | 238 | 0.050 |
Why?
|
Biopsy | 1 | 2014 | 6781 | 0.050 |
Why?
|
Ireland | 1 | 2022 | 169 | 0.050 |
Why?
|
Adolescent | 6 | 2023 | 88300 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3805 | 0.050 |
Why?
|
Models, Structural | 1 | 2022 | 338 | 0.050 |
Why?
|
Ritonavir | 1 | 2023 | 329 | 0.050 |
Why?
|
Prednisolone | 1 | 2022 | 324 | 0.050 |
Why?
|
B-Cell Activating Factor | 1 | 2021 | 115 | 0.050 |
Why?
|
Fabaceae | 1 | 2021 | 103 | 0.050 |
Why?
|
Synovial Fluid | 1 | 2023 | 393 | 0.050 |
Why?
|
Putrescine | 1 | 2020 | 42 | 0.050 |
Why?
|
Xenobiotics | 1 | 2021 | 70 | 0.050 |
Why?
|
B-Lymphocytes | 2 | 2024 | 4744 | 0.050 |
Why?
|
Butyric Acid | 1 | 2020 | 51 | 0.050 |
Why?
|
Spermidine | 1 | 2020 | 62 | 0.050 |
Why?
|
Databases, Factual | 3 | 2021 | 7965 | 0.040 |
Why?
|
Spondylarthropathies | 1 | 2020 | 14 | 0.040 |
Why?
|
Phosphatidylethanolamines | 1 | 2020 | 129 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 628 | 0.040 |
Why?
|
Pulmonary Fibrosis | 1 | 2024 | 505 | 0.040 |
Why?
|
Caprylates | 1 | 2020 | 115 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2023 | 537 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2023 | 4340 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36415 | 0.040 |
Why?
|
Azetidines | 1 | 2020 | 142 | 0.040 |
Why?
|
Carnitine | 1 | 2020 | 252 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2024 | 724 | 0.040 |
Why?
|
Nuts | 1 | 2021 | 264 | 0.040 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 299 | 0.040 |
Why?
|
Translations | 1 | 2019 | 81 | 0.040 |
Why?
|
Synovial Membrane | 1 | 2022 | 532 | 0.040 |
Why?
|
Blood Urea Nitrogen | 1 | 2018 | 186 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2024 | 725 | 0.040 |
Why?
|
Cyclooxygenase 1 | 1 | 2018 | 97 | 0.040 |
Why?
|
Linear Models | 2 | 2020 | 5869 | 0.040 |
Why?
|
Tryptophan | 1 | 2020 | 480 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2024 | 976 | 0.040 |
Why?
|
Mass Screening | 2 | 2024 | 5426 | 0.040 |
Why?
|
Immunotherapy | 2 | 2024 | 4642 | 0.040 |
Why?
|
Methionine | 1 | 2020 | 570 | 0.040 |
Why?
|
Diet Records | 1 | 2019 | 427 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20118 | 0.040 |
Why?
|
Transaminases | 1 | 2018 | 199 | 0.040 |
Why?
|
Interleukins | 1 | 2022 | 782 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11476 | 0.040 |
Why?
|
Muscular Diseases | 1 | 2022 | 552 | 0.040 |
Why?
|
Telomere | 1 | 2024 | 939 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8837 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2023 | 26200 | 0.040 |
Why?
|
Self Report | 2 | 2022 | 3727 | 0.040 |
Why?
|
Purines | 1 | 2020 | 609 | 0.040 |
Why?
|
DNA | 2 | 2021 | 7189 | 0.040 |
Why?
|
Phosphofructokinase-2 | 1 | 2016 | 33 | 0.030 |
Why?
|
Beer | 1 | 2017 | 134 | 0.030 |
Why?
|
Propensity Score | 1 | 2024 | 1916 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2018 | 321 | 0.030 |
Why?
|
Pregnant Women | 1 | 2021 | 568 | 0.030 |
Why?
|
Waist Circumference | 1 | 2020 | 933 | 0.030 |
Why?
|
Wine | 1 | 2017 | 166 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 1783 | 0.030 |
Why?
|
Kinetics | 1 | 2024 | 6312 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 668 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2082 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2021 | 1176 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1550 | 0.030 |
Why?
|
Vasculitis | 1 | 2020 | 522 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1838 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2475 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2019 | 634 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 29893 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1666 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14675 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2022 | 4567 | 0.030 |
Why?
|
Menarche | 1 | 2017 | 532 | 0.030 |
Why?
|
Placebo Effect | 1 | 2018 | 518 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2021 | 738 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2015 | 317 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1878 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3584 | 0.030 |
Why?
|
Creatinine | 1 | 2018 | 1897 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2854 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2928 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2018 | 1002 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2024 | 3691 | 0.020 |
Why?
|
Medical Informatics | 1 | 2019 | 733 | 0.020 |
Why?
|
Program Development | 1 | 2018 | 1294 | 0.020 |
Why?
|
Fear | 1 | 2020 | 1477 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3328 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3134 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7226 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2004 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1803 | 0.020 |
Why?
|
Genomics | 2 | 2020 | 5829 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1977 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2018 | 1063 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2018 | 1506 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 2010 | 0.020 |
Why?
|
Th17 Cells | 1 | 2016 | 794 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2016 | 1891 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2923 | 0.020 |
Why?
|
Anthropometry | 1 | 2014 | 1338 | 0.020 |
Why?
|
Crohn Disease | 1 | 2022 | 2278 | 0.020 |
Why?
|
Haplotypes | 1 | 2015 | 2715 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12747 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2018 | 3210 | 0.020 |
Why?
|
Qualitative Research | 1 | 2018 | 3024 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9319 | 0.020 |
Why?
|
Energy Intake | 1 | 2014 | 2133 | 0.020 |
Why?
|
Animals | 3 | 2024 | 168089 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2022 | 18927 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12985 | 0.020 |
Why?
|
Models, Genetic | 1 | 2015 | 3430 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81330 | 0.010 |
Why?
|
Curriculum | 1 | 2018 | 3741 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14392 | 0.010 |
Why?
|
Blood Pressure | 1 | 2018 | 8479 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6774 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22128 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 30004 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36170 | 0.010 |
Why?
|
Stroke | 1 | 2018 | 9721 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12159 | 0.010 |
Why?
|